Cargando…

2'-Deoxythymidine Adducts from the Anti-HIV Drug Nevirapine

Nevirapine (NVP) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used against HIV-1. Currently, NVP is the most widely used anti-HIV drug in developing countries, both in combination therapy and to prevent mother-to-child transmission of HIV. Despite its efficacy against HIV, NVP produce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antunes, Alexandra M. M., Wolf, Benjamin, Oliveira, M. Conceição, Beland, Frederick A., Marques, M. Matilde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269667/ https://www.ncbi.nlm.nih.gov/pubmed/23624649 http://dx.doi.org/10.3390/molecules18054955

Ejemplares similares

Covalent Histone Modification by an Electrophilic Derivative of the Anti-HIV Drug Nevirapine
por: Harjivan, Shrika G., et al.
Publicado: (2021)

Oxidation of 2-Hydroxynevirapine, a Phenolic Metabolite of the Anti-HIV Drug Nevirapine: Evidence for an Unusual Pyridine Ring Contraction
por: Antunes, Alexandra M. M., et al.
Publicado: (2012)

Sex differences in apolipoprotein A1 and nevirapine-induced toxicity
por: Marinho, Aline, et al.
Publicado: (2014)

Nevirapine Biotransformation Insights: An Integrated In Vitro Approach Unveils the Biocompetence and Glutathiolomic Profile of a Human Hepatocyte-Like Cell 3D Model
por: Cipriano, Madalena, et al.
Publicado: (2020)

Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas.
por: Rehn, S., et al.
Publicado: (1995)

Increased deoxythymidine triphosphate levels is a feature of relative cognitive decline
por: Desler, Claus, et al.
Publicado: (2015)

Cutaneous drug-reactions to nevirapine: study of risk factors in 268 HIV-infected patients
por: Badaoui, L, et al.
Publicado: (2014)

RADIOAUTOGRAPHIC LOCALIZATION OF DEOXYTHYMIDINE TRIPHOSPHATE IN TRADESCANTIA POLLEN GRAINS DURING DNA SYNTHESIS
por: Takats, S. T.
Publicado: (1968)

Influence of quinacrine and chloroquine on the in vitro 3′-azido-3′-deoxythymidine antiretroviral effect
por: Torres, Klintsy J, et al.
Publicado: (2015)

Formation and persistence of arylamine DNA adducts in vivo.
por: Beland, F A, et al.
Publicado: (1985)

Twelfth-Position Deuteration of Nevirapine Reduces 12-Hydroxy-Nevirapine Formation and Nevirapine-Induced Hepatocyte Death
por: Heck, Carley J. S., et al.
Publicado: (2020)

DNA adduct measurements and tumor incidence during chronic carcinogen exposure in rodents.
por: Poirier, M C, et al.
Publicado: (1994)

Crystal structure of ammonium 3′-azido-3′-deoxythymidine-5′-aminocarbonylphosphonate hemihydrate: an anti-HIV agent
por: Jasko, Maxim V., et al.
Publicado: (2014)

Nevirapine Resistance and Breast-Milk HIV Transmission: Effects of Single and Extended-Dose Nevirapine Prophylaxis in Subtype C HIV-Infected Infants
por: Moorthy, Anitha, et al.
Publicado: (2009)

Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children
por: Gonzalez-Tome, M Isabel, et al.
Publicado: (2008)

Significance of DNA adduct studies in animal models for cancer molecular dosimetry and risk assessment.
por: Beland, F A, et al.
Publicado: (1993)

Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis
por: Permar, Sallie R, et al.
Publicado: (2013)

A new family of globally distributed lytic roseophages with unusual deoxythymidine to deoxyuridine substitution
por: Rihtman, Branko, et al.
Publicado: (2021)

Nevirapine induced exfoliative dermatitis in an HIV-infected patient
por: Bhandarkar, Anoosha P., et al.
Publicado: (2011)

Biphasic removal of DNA adducts in a repetitive DNA sequence after dietary administration of 2-acetylaminofluorene.
por: Culp, S J, et al.
Publicado: (1993)

Floating Drug Delivery of Nevirapine as a Gastroretentive System
por: Vedha, Hari BN, et al.
Publicado: (2010)

Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis
por: Beland, Frederick A., et al.
Publicado: (1983)

The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma.
por: Gronowitz, J. S., et al.
Publicado: (1983)

Structural insights into RNA polymerase III-mediated transcription termination through trapping poly-deoxythymidine
por: Hou, Haifeng, et al.
Publicado: (2021)

Nevirapine induced Stevens–Johnson syndrome in an HIV infected patient
por: Singh, Harminder, et al.
Publicado: (2011)

Adverse Events in a Cohort of HIV Infected Pregnant and Non-Pregnant Women Treated with Nevirapine versus Non-Nevirapine Antiretroviral Medication
por: Aaron, Erika, et al.
Publicado: (2010)

Incidence and Determinants of Nevirapine and Efavirenz-Related Skin Rashes in West Africans: Nevirapine's Epitaph?
por: Sarfo, Fred Stephen, et al.
Publicado: (2014)

Electronic Structure of the Azide Group in 3′-Azido-3′-deoxythymidine (AZT) Compared to Small Azide Compounds
por: Chen, Fang-Fang, et al.
Publicado: (2009)

In vivo Evaluation of Self Emulsifying Drug Delivery System for Oral Delivery of Nevirapine
por: Chudasama, A. S., et al.
Publicado: (2014)

Identification of Drug Resistant Mutations in HIV-1 CRF07_BC Variants Selected by Nevirapine In Vitro
por: Wu, Hao, et al.
Publicado: (2012)

Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana
por: Maseng, Monkgomotsi J, et al.
Publicado: (2021)

Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique
por: Antunes, Francisco, et al.
Publicado: (2015)

Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship
por: Bhatt, Nilesh B., et al.
Publicado: (2015)

Solid-State Characterization of Nevirapine
por: Sarkar, Mahua, et al.
Publicado: (2008)

Co-administration of fluconazole increases nevirapine concentrations in HIV-infected Ugandans
por: Wakeham, Katie, et al.
Publicado: (2010)

Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-naïve HIV-1-infected individuals
por: Pereira, A, et al.
Publicado: (2010)

Development of a liposomal nanodelivery system for nevirapine
por: Ramana, Lakshmi N, et al.
Publicado: (2010)

Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole
por: Manosuthi, Weerawat, et al.
Publicado: (2007)

Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi
por: Dickinson, L, et al.
Publicado: (2010)

Formulation, optimization, and evaluation of self-emulsifying drug delivery systems of nevirapine
por: Chintalapudi, Ramprasad, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7r83ujkpcmcrnepheohhdhso8k